People: Columbia Laboratories, Inc. (CBRX.O)

CBRX.O on Consolidated Issue listed on NASDAQ Global Market

1.26USD
9 Feb 2010
Price Change (% chg)

$-0.02 (-1.56%)
Prev Close
$1.26
Open
--
Day's High
$1.40
Day's Low
$1.26
Volume
435,032
Avg. Vol
401,933
52-wk High
$1.74
52-wk Low
$0.65

view people for:

Summary

Name Age Since Current Position
Kasnet, Stephen 63 2004 Chairman of the Board
Condella, Frank 55 2009 Interim Chief Executive Officer, Director
Mills, Robert 56 2009 President, Chief Operating Officer, Director
Blechschmidt, Edward 57 2004 Vice Chairman of the Board
Gyenes, Lawrence 57 2009 Chief Financial Officer, Senior Vice President, Treasurer
McGrane, Michael 59 2006 Senior Vice President, General Counsel, Secretary
Oskowitz, Selwyn 63 1999 Director
Andrews, Valerie 49 2005 Director
Crofton, James 57 2005 Director
Campbell, Anthony 61 2008 Director
» Insider Trading

Biographies

Name Description
Kasnet, Stephen Stephen G. Kasnet has been a director of Columbia Laboratories Inc. since August 2004 and Chairman of the Board since November 2004. He has been President and Chief Executive Officer of Raymond Property Company LLC (real estate) since April, 2007. He was President and Chief Executive Officer of Harbor Global Company, Ltd. (real estate investments), from June 2000 through 2006. He previously held senior management positions with various financial organizations, including Pioneer Group, Inc.; First Winthrop Corporation and Winthrop Financial Associates; and Cabot, Cabot and Forbes. He serves as Chairman of the Board of Rubicon Ltd. (forestry) and is a director of Tenon Ltd. (wood products). He was Chairman of Warren Bank from 1990 to 2003. He is also a trustee and vice president of the board of The Governor’s Academy, Byfield, MA.
Condella, Frank Frank C. Condella, Jr. has been a Director of Columbia Laboratories Inc. since March 2009 and has been appointed as Interim Chief Executive Officer effective December 15, 2009. In addition to his position at Columbia Laboratories, Mr. Condella currently serves on the board of directors at SkyePharma plc as chairman-elect and as a director on the board of directors at Fulcrum Pharma plc. Mr. Condella also served as chief executive officer of SkyePharma from 2006 to 2008. Previously, he was president of European Operations at IVAX, chief executive officer of Faulding Pharmaceutical Co., vice president of the Specialty Care Products at Roche and vice president and General Manager of the Lederle unit of American Home Products. Mr. Condella holds a BS in Pharmacy and an MBA from Northeastern University.
Mills, Robert Robert S. Mills has been a Director of Columbia Laboratories Inc. since January 2006 and has been appointed as President and Chief Operating Officer effective December 15, 2009. He had been the Company’s President and Chief Executive Officer since March 2006. Prior to that Mr. Mills was Senior Vice President of the Company from May 2001 and Chief Operating Officer of the Company from October 2003. Prior to joining the Company in 2001, Mr. Mills served as Senior Vice President, Manufacturing Operations, at Watson Pharmaceuticals and General Manager of Schein Pharmaceuticals, now Watson Pharma, Inc. During his 30-year career in the pharmaceutical industry he also served as Vice President, Operations, at Alpharma, Inc. (pharmaceuticals) and held various positions with Aventis, SA (pharmaceuticals).
Blechschmidt, Edward Edward A. Blechschmidt has been a director of Columbia Laboratories Inc. since August 2004 and Vice Chairman of the Board since November 2004. He was Chief Executive Officer of Novelis, Inc. (aluminum rolled products) from December 2006 to May 2007. He was Chairman, Chief Executive Officer and President of Gentiva Health Services (home healthcare) from March 2000 until his retirement in July 2002. He previously served as Chief Executive Officer of Olsten Corporation (“Olsten”) (staffing services), the conglomerate from which Gentiva Health Services was split off and taken public. Before joining Olsten, Mr. Blechschmidt was President and Chief Executive Officer of both Siemens' Nixdorf Americas (information technology) and Siemens' Pyramid Technology (information technology), prior to which he served more than 20 years with Unisys Corporation (information technology), ultimately as Chief Financial Officer. He is currently a director of Health South Corp. (healthcare), Lionbridge Technologies, Inc. (business services), Diamond Foods, Inc. (snack-foods), and VWR International, LLC, (laboratory supplies).
Gyenes, Lawrence Mr. Lawrence Gyenes is Chief Financial Officer, Senior Vice President, Treasurer of Columbia Laboratories, Inc. Mr. Gyenes has over 35 years of financial experience in both privately and publicly held companies, most of which were in the life sciences industry. He most recently served as Senior Vice President and Chief Financial Officer of Acusphere, Inc., a former NASDAQ-listed specialty pharmaceutical company. Prior to joining Acusphere, Mr. Gyenes was Chief Financial Officer of Zila, Inc., a NASDAQ-listed oral cancer screening company, a consultant to investment management firms, and Senior Vice President and Chief Financial Officer of Savient Pharmaceuticals, Inc., a NASDAQ-listed specialty pharmaceutical company. He also held senior financial positions with Reliant Pharmaceuticals, Inc., Rand McNally & Co., CompuServe Corporation, Helene Curtis, Inc., and G.D. Searle & Co. and was a consultant to DuPont Pharmaceuticals Company in its sale to Bristol-Myers Squibb. Mr. Gyenes holds an Master of Business Administration degree from the University of Chicago and a Bachelor of Science degree in Accounting from the University of Illinois.
McGrane, Michael Michael McGrane has served as Senior Vice President of Columbia Laboratories Inc. since January 2006, and General Counsel and Secretary since January 2002. He joined the Company from The Liposome Company, Inc., a biotechnology company, where he served as Vice President, General Counsel and Secretary from 1999 to 2001, prior to which he was Vice President, General Counsel and Secretary to Novartis Consumer Health, Inc. from 1997 to 1998. Previously, Mr. McGrane held various positions, including Associate General Counsel, with Novartis Pharmaceuticals Corporation from 1984 to 1996, and was Regulatory Counsel to the U.S. Food and Drug Administration from 1975 to 1984. Mr. McGrane received his J.D. degree from Georgetown University and his B.A. degree from Cornell College. He is a member of the New Jersey bar.
Oskowitz, Selwyn Selwyn P. Oskowitz, M.D. has been a director of Columbia Laboratories Inc. since January 1999. Dr. Oskowitz has been an assistant professor of obstetrics, gynecology, and reproductive biology at Harvard Medical School since 1993. Dr. Oskowitz is a reproductive endocrinologist at, and Director of, Boston IVF, a fertility clinic with which he has been associated since 1986. Dr. Oskowitz is a past President of the Boston Fertility Society.
Andrews, Valerie Valerie L. Andrews has been a director of Columbia Laboratories Inc. since October 2005 and is Vice President, Deputy General Counsel, and Chief Compliance Officer of Vertex Pharmaceuticals Inc. Before joining Vertex in 2002, Ms. Andrews was Executive Director of Licensing for Massachusetts General and The Brigham and Women’s Hospitals, and prior to that a partner in the law firm of Hill & Barlow. She served as a law clerk to Chief Judge Levin H. Campbell of the United States Court of Appeals for the First Circuit from 1988 to 1989, and earlier rose to the rank of Captain in the United States Air Force.
Crofton, James James S. Crofton has been a director of Columbia Laboratories Inc. since October 2005. He has been Senior Vice President and Chief Financial Officer of Sarnoff Corporation (technology) since 1999. Previously, Mr. Crofton was Chief Financial Officer of EA Industries, Inc. (electronics manufacturing), and prior to that served in various positions, including Vice President of Finance, with Unisys Corporation (information technology).
Campbell, Anthony Anthony R. Campbell has been a director of Columbia Laboratories Inc. since December 2008 and is a Portfolio Manager and Senior Analyst for Dorset Management Corporation since January 2000 and a Director of Knott Partners Management, LLC (investment advisors) since 2004. Mr. Campbell founded Windsor Partners, L.P. (investment advisors) in 1986. He was Principal and Managing Director of Berg Capital Corporation, a registered investment advisor, from 1984 through 1985, and also served as General Partner of Chelsea Partners, a private investment partnership, during that time. Mr. Campbell was a Vice President at the First Boston Corporation from 1975 through 1984, and from 1969 until 1975 was at McLeod, Young, Weir, Ltd. (investment advisors) in Canada where he was appointed a Vice President in 1973.

Basic Compensation

Name Fiscal Year Total
Kasnet, Stephen --
Condella, Frank --
Mills, Robert 660,886
Blechschmidt, Edward --
Gyenes, Lawrence --
McGrane, Michael 464,373
Oskowitz, Selwyn --
Andrews, Valerie --
Crofton, James --
Campbell, Anthony --
As Of 30 Dec 2008

Options Compensation

Name Options Value
Kasnet, Stephen 0 0
Condella, Frank 0 0
Mills, Robert 550,725 1,275,338
Blechschmidt, Edward 0 0
Gyenes, Lawrence 0 0
McGrane, Michael 336,310 392,197
Oskowitz, Selwyn 0 0
Andrews, Valerie 0 0
Crofton, James 0 0
Campbell, Anthony 0 0

Insider Trading

Name Shares Traded Price
OSKOWITZ SELWYN PHILLIP 700 $0.99
KASNET STEPHEN GARFIELD 10,000 $0.99
OSKOWITZ SELWYN PHILLIP 1,000 $0.85
KASNET STEPHEN GARFIELD 40,000 $0.85
GYENES LAWRENCE A 50,000 $0.87
CONDELLA FRANK JR 12,000 $0.01
CONDELLA FRANK JR 14,400 $1.29
CONDELLA FRANK JR 12,000 $0.01
CONDELLA FRANK JR 12,000 $0.01
CONDELLA FRANK JR 12,000 $0.01
KASNET STEPHEN GARFIELD 3,448 $1.30
OSKOWITZ SELWYN PHILLIP 3,448 $1.30
CROFTON JAMES 19,230 $0.01
CAMPBELL ANTHONY R 8,333 $1.30
ANDREWS VALERIE LYNNE 19,230 $0.01
BLECHSCHMIDT EDWARD A 19,230 $0.01
O DONNELL DENIS M 3,448 $1.30
CONDELLA FRANK JR 19,230 $0.01
CROFTON JAMES 3,448 $1.30
KASNET STEPHEN GARFIELD 19,230 $0.01
ANDREWS VALERIE LYNNE 3,448 $1.30
OSKOWITZ SELWYN PHILLIP 19,230 $0.01
BLECHSCHMIDT EDWARD A 3,448 $1.30
CAMPBELL ANTHONY R 19,230 $0.00
CONDELLA FRANK JR 6,622 $1.30
» Full list on Insider Trading
view people for: